SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-010949
Filing Date
2021-05-11
Accepted
2021-05-11 07:30:50
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 400079
2 ex31-1.htm EX-31.1 18764
3 ex31-2.htm EX-31.2 18882
4 ex32-1.htm EX-32.1 7173
5 ex32-2.htm EX-32.2 7242
  Complete submission text file 0001493152-21-010949.txt   2844647

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20210331.xml EX-101.INS 393503
7 XBRL SCHEMA FILE xtnt-20210331.xsd EX-101.SCH 36845
8 XBRL CALCULATION FILE xtnt-20210331_cal.xml EX-101.CAL 65665
9 XBRL DEFINITION FILE xtnt-20210331_def.xml EX-101.DEF 109640
10 XBRL LABEL FILE xtnt-20210331_lab.xml EX-101.LAB 281890
11 XBRL PRESENTATION FILE xtnt-20210331_pre.xml EX-101.PRE 219478
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 21909626
SIC: 2836 Biological Products, (No Diagnostic Substances)